Colorectal Cancer (CRC) Unknown Status Phase 1 Trials for Oxaliplatin (DB00526)

Back to Colorectal Cancer (CRC)

Also known as: Malignant Neoplasm of Colorectum / CRC, Colorectal Cancer / Colorectal Cancer / Cancer, Colorectal / CRC (Colorectal Cancer) / Colorectal, Cancer / Colo-rectal Cancer / Colorectal Cancers / A. Colorectal Cancer / Cancer Colorectal / Gastrointestinal Cancers - Colorectal / CRC / CRCS / Malignant colorectal neoplasm / Malignant neoplasm of cecum and/or colon and/or rectum / Malignant neoplasm of caecum and/or colon and/or rectum / Malignant neoplasm of cecum and/or colon and/or rectum (disorder) / Malignant neoplasm of large intestine / Malignant tumor of large intestine / Malignant tumour of large intestine / Malignant neoplasm of large intestine (disorder) / Malignant neoplasm of colon, unspecified / Malignant large intestinal neoplasm NOS / Cancer of large intestine / Malignant neoplasm of large intestine, NOS / Cancer of large bowel / CA - Cancer of large bowel / Colorectal neoplasms malignant / Malignant neoplasm of colon and/or rectum (disorder) / Large intestine carcinoma / Colorectal carcinoma / Colorectal cancer NOS

Indication	Status	Phase
DBCOND0031867 (Colorectal Cancer (CRC))	Unknown Status	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT06394791	Evaluation of The Efficacy And Safety of PD-1 + IL-2 Combined With Capox Treatment After Loop Colostomy Surgery in Left-sided Colorectal Cancer Patients Complicating Acute Obstruction	Treatment	Capecitabine (DB01101) Human interleukin-2 (DB14865) Oxaliplatin (DB00526) Tislelizumab (DB14922)
NCT04337879	A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer	Treatment	AL2846 (DB25238) Irinotecan (DB00762) Oxaliplatin (DB00526)
NCT04202978	Camrelizumab Combined With Apatinib 、XELOX 、RFA in the Treatment of Liver Metastases of Colorectal Cancer	Treatment	Camrelizumab (DB14776) Capecitabine (DB01101) Oxaliplatin (DB00526) Rivoceranib (DB14765)
NCT00854971	Efficacy Study of TKcell in Advanced Colorectal Cancer	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00524706	Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer	Treatment	Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT05590117	Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer	Prevention	Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526) Pentoxifylline (DB00806)
NCT05056389	Normothermic Intraperitoneal Chemotherapy - Long Term in Peritoneal Metastases From Colorectal Cancer (NIPEC-OXA)	Treatment	Oxaliplatin (DB00526)
NCT00496704	Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan	Treatment	Capecitabine (DB01101) Gemcitabine (DB00441) Oxaliplatin (DB00526)
NCT05721872	Efficacy, Tolerability and Safety of Intravenous D-VC With ATO in Patients With Advanced/Metastatic Colorectal Cancer	Treatment	Arsenic trioxide (DB01169) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT04380103	A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer	Treatment	Bevacizumab (DB00112) Capecitabine (DB01101) Irinotecan (DB00762) Oxaliplatin (DB00526)